Acetaminophen, Aspirin (NSAID), and Caffeine
CHEBI:CHEBI_747007
Drug Classification
-
chemical entityView Class →
CHEBI:24431
Important Medical Information
⚕️ This information is sourced from ChEBI (Chemical Entities of Biological Interest) database and is intended for educational purposes only.
- Always consult with a healthcare professional before starting, stopping, or modifying any medication.
- Side effects may vary and this list may not be comprehensive.
- Drug interactions may occur with other medications.
Additional Identifiers
🔍 Click on any linked disease name to learn more about the conditions this medication is used to treat, or explore related drug classifications for more information about similar medications.
Additional Attributes
- brand_name_suffix
- MIGRAINE
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
- dosage_form
- TABLET, FILM COATED
- marketing_category
- OTC MONOGRAPH DRUG
- listing_expiration_date
- 20251231
- route
- ORAL
- product_type
- HUMAN OTC DRUG
- marketing_start_date
- 20100215
- application_number
- NDA020802
- labeler_name
- Navajo Manufacturing Company Inc.
- generic_name
- Acetaminophen, Aspirin (NSAID) and Caffeine
- brand_name
- Excedrin Migraine Relief
- brand_name_base
- EXCEDRIN
- product_ndc
- 0067-8202
- spl_id
- 93bc5c3b-f2e7-41e3-aa3a-0a181c3477cf
- package_ndc
- 0067-8202-03
- package_description
- 1 BOTTLE in 1 CARTON (0067-8202-03) / 300 TABLET, FILM COATED in 1 BOTTLE
- active_ingredient_name
- ASPIRIN
- rxcui
- 404172
- pharm_class
- Decreased Platelet Aggregation [PE]
- unii
- R16CO5Y76E
- active_ingredient_strength
- 65 mg/1
- nui
- N0000008832
- pharm_class_epc
- Platelet Aggregation Inhibitor [EPC]
- pharm_class_moa
- Cyclooxygenase Inhibitors [MoA]
- pharm_class_cs
- Xanthines [CS]
- pharm_class_pe
- Decreased Platelet Aggregation [PE]
- package_marketing_start_date
- 20180930
- manufacturer_name
- Navajo Manufacturing Company Inc.
- spl_set_id
- 691b754c-bafc-47e2-a322-cf56245c01f6